Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Therapy with Direct-Acting Antivirals. A Systematic Review and Meta-Analysis

Background: Hepatocellular carcinoma (HCC) is a major cause of morbidity and mortality among patients with cirrhosis. The risk of HCC recurrence after a complete response among patients treated with direct-acting antivirals (DAAs) has not been fully elucidated yet. Aim: To assess the risk of HCC rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Frazzoni, Leonardo, Sikandar, Usama, Metelli, Flavio, Sadalla, Sinan, Mazzella, Giuseppe, Bazzoli, Franco, Fuccio, Lorenzo, Azzaroli, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071154/
https://www.ncbi.nlm.nih.gov/pubmed/33920785
http://dx.doi.org/10.3390/jcm10081694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071154/
https://www.ncbi.nlm.nih.gov/pubmed/33920785
http://dx.doi.org/10.3390/jcm10081694

Ejemplares similares